Peritoneal papillary serous carcinoma: Study of 15 cases and comparison with stage iii–iv ovarian papillary serous carcinoma

Piura, Benjamin; Meirovitz, Mihai; Bartfeld, Mary; Yanai‐Inbar, Ilana; Cohen, Yoram

doi:10.1002/(sici)1096-9098(199807)68:3<173::aid-jso8>3.0.co;2-2

Cited by 26 publications

(6 citation statements)

References 24 publications

(27 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our finding of a significantly higher median age at menarche among PPC compared to POC patients is in line with some [8,16] but not all former studies [12]. None of the previous estimates reached a significant level.…”

Section: Discussionsupporting

confidence: 90%

Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology — A prospective comparative study

Schnack

Sörensen

Nedergaard

et al. 2014

Gynecologic Oncology

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 90%

Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology — A prospective comparative study

Schnack

Sörensen

Nedergaard

et al. 2014

Gynecologic Oncology

View full text Add to dashboard Cite

“…This rate is consistent with the rates of optimal cytoreductive surgery (defined as ≤2.0 cm residual tumors), which have been reported to vary between 33 and 69% by other investigators [7, 8, 9]. Several comparative and case-control studies seem to have suggested that PPC and OSC have similar prognoses [4, 10], whereas other series have suggested poorer survival in PPC [8]. In our study, PFS was significantly greater in the OSC patients than in the PPC patients, although OS was similar in both groups.…”

Section: Discussionsupporting

confidence: 88%

Paclitaxel plus Carboplatin Chemotherapy for Primary Peritoneal Carcinoma: A Study of 22 Cases and Comparison with Stage IIIIV Ovarian Serous Carcinoma

Kawaguchi

Tanase²,

Shoji³

et al. 2012

Case Rep Oncol

View full text Add to dashboard Cite

The aim of this study was to assess the clinical characteristics and outcome of patients with either primary peritoneal carcinoma (PPC) or ovarian serous carcinoma (OSC) treated with paclitaxel plus carboplatin chemotherapy. We retrospectively identified 22 PPC patients and 55 stage III–IV OSC patients treated between 2002 and 2007. After exploratory laparotomy, all patients received paclitaxel and carboplatin every 3 weeks, with the goal of optimal cytoreduction. There were no statistically significant differences between the PPC and OSC groups with regard to tumor stage, residual tumor after debulking surgery (initial or interval), serum cancer antigen (CA) 125 levels at diagnosis, and completion of first-line chemotherapy. The progression-free survival (PFS) durations were 12.7 months (95% CI, 6.3–18.5) in the patients with PPC and 15.9 months (95% CI, 13.3–18.5) in those with OSC (p = 0.016). However, the median survival durations were 26.5 months (95% CI, 14.6–38.3) in the patients with PPC and 38 months (95% CI, 23.8–53.8) in those with OSC (p = 0.188). Survival was longer for all patients whose CA125 levels normalized to 26 U/ml during and after treatment. Overall survival (OS) of the patients with PPC was similar to that of the patients with OSC, suggesting that management for advanced-stage OSC would be similar to that for PPC. The combination of optimal debulking with paclitaxel plus carboplatin chemotherapy may offer patients the most effective treatment. The CA125 nadir after cytoreductive surgery can be considered a prognostic factor for OS and PFS in patients with PPC.

show abstract

“…Both primary ovarian carcinoma and primary peritoneal cystadenocarcinoma can present with carcinomatosis. Clinical presentation results from local tumor effects involving multiple organs [ 3 ]. Common symptoms include abdominal distension/ascites, dyspnea, nausea, vomiting and constipation.…”

Section: Introductionmentioning

confidence: 99%

Immunohistochemical identification of primary peritoneal serous cystadenocarcinoma mimicking advanced colorectal carcinoma: a case report

et al. 2007

View full text Add to dashboard Cite

Primary peritoneal cystadenocarcinoma is a rare tumor of similar histogenic origin as primary ovarian carcinoma. We present a case of primary peritoneal serous cystadenocarcinoma mimicking advanced colorectal cancer in a 68 yr-old African American female. Radiology, endoscopy and cytology yielded only inconclusive findings. Immunohistochemical analysis of percutaneously obtained ascitic fluid provided a correct diagnosis of primary peritoneal cystadenocarcinoma. The discovery of serous ascites at the time of laparotomy confirmed a diagnosis of primary peritoneal serous cystadenocarcinoma. Final surgical pathology reconfirmed the diagnosis of primary peritoneal cystadenocarcinoma. This case demonstrates the utility of immunohistochemistry for accurately diagnosing patients with inconclusive findings in the setting of peritoneal carcinomatosis and primary peritoneal cystadenocarcinoma.

show abstract

Peritoneal papillary serous carcinoma: Study of 15 cases and comparison with stage iii–iv ovarian papillary serous carcinoma

Cited by 26 publications

References 24 publications

Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology — A prospective comparative study

Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology — A prospective comparative study

Paclitaxel plus Carboplatin Chemotherapy for Primary Peritoneal Carcinoma: A Study of 22 Cases and Comparison with Stage IIIIV Ovarian Serous Carcinoma

Immunohistochemical identification of primary peritoneal serous cystadenocarcinoma mimicking advanced colorectal carcinoma: a case report

Contact Info

Product

Resources

About

Peritoneal papillary serous carcinoma: Study of 15 cases and comparison with stage iii–iv ovarian papillary serous carcinoma

Cited by 26 publications

References 24 publications

Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology — A prospective comparative study

Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology — A prospective comparative study

Paclitaxel plus Carboplatin Chemotherapy for Primary Peritoneal Carcinoma: A Study of 22 Cases and Comparison with Stage IIIIV Ovarian Serous Carcinoma

Immunohistochemical identification of primary peritoneal serous cystadenocarcinoma mimicking advanced colorectal carcinoma: a case report

Contact Info

Product

Resources

About

Paclitaxel plus Carboplatin Chemotherapy for Primary Peritoneal Carcinoma: A Study of 22 Cases and Comparison with Stage IIIIV Ovarian Serous Carcinoma